#Nasalspray #Pharma #Marketing #GLP-1 #Drugs #China #World On January 12, 2026, Chinas Center for Drug Evaluation (CDE) reached a major milestone by approving Shiling Pharmas Semaglutide Nasal Spray to enter clinical trials for long-term weight management. #medicine #product This isn't just another "me-too" drug
Pallars y cols., encontraron alteraciones moderadas de las pruebas analticas en un 78% de los pacientes que recibieron NP y que no tenan disfuncin heptica previa
Starting Your Personalised Path to Sustainable Weight Loss Reaching your health goals in 2026 doesnt have to be a battle against your own biology
But if youre lacking on the fiber front and cant find it in your day-to-day diet due to dietary restrictions, lifestyle, or otherwise, a fiber supplement could help
The European regulatory approval of afamelanotide (Scenesse) for erythropoietic protoporphyria (EPP) was supported by Phase 3 randomized controlled trials demonstrating significantly increased pain-free light exposure time in EPP patients validating MC1R-mediated photoprotection as a real biological effect
